Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

305 results about "Chemical binding" patented technology

Chemical bonding happens when two or more atoms join together to form a molecule. It is a general principle in science that all systems will try to reach their lowest energy level, and chemical bonding will only take place when a molecule can form that has less energy than its uncombined atoms.

Methods of treating chronic inflammatory diseases using carbonyl trapping agents

InactiveUS6444221B1Improved therapeutic propertyImprove propertiesBiocidePeptide/protein ingredientsEtiologyBenzoic acid
These and other objects of this invention are achieved by providing a novel method and compositions for the clinical treatment of chronic inflammatory diseases. This invention involves use of systemically administered compositions which include primary amine derivatives of benzoic acid as carbonyl trapping agents. These primary therapeutic agents act by chemically binding to and sequestering the aldehyde and/or ketone products of lipid peroxidation. Increased levels of lipid peroxidation have been repeatedly demonstrated as a part of the non-enzymatic "inflammatory cascade" process which underlies the secondary etiology of chronic inflammatory diseases. p-Aminobenzoic acid (or PABA) is an example of the primary therapeutic agent of the present invention. PABA has a small molecular weight, is water soluble, has a primary amine group that reacts with carbonyl-containing metabolites under physiological conditions and is tolerated by the body in relatively high dosages and for extended periods. The carbonyl sequestering agents are used in combination with at least one co-agent so as to produce an additional beneficial physiological effect of an anti-inflammatory nature. Such compositions are administered systemically entirely via the oral route. Co-agents of the present invention include anti-oxidants and free radical trapping compounds (e.g., alpha-tocopherol), compounds having indirect anti-oxidant activity (e.g., selenium), vitamins (e.g., pyridoxine HCl), compounds which facilitate kidney drug elimination (e.g., glycine), metabolites at risk of depletion (e.g., pantothenic acid), sulfhydryl containing chemicals (e.g., methionine), compounds which facilitate glutathione activity (e.g., N-acetylcysteine), and non-absorbable polyamine co-agents (e.g., chitosan).
Owner:SECANT PHARMA

Physically/molecularly distributed and/or chemically bound medicaments in empty, hard capsule shells

The present invention incorporates medicaments in the empty hard capsule shells (body and cap). The medicament is either physically / molecularly distributed and / or chemically bound to the polymer matrix of the capsule shell composition. Other medicaments in the form of drug-loaded matrices (powders, granules, beads, pellets, mini-tablets, and mini-capsules) can be filled in the drug-loaded empty, hard capsule shells. The same capsule dosage form contains medicaments in the core matrix and in the shell.
Owner:JOSHI HEMANT N +1

Surface-enhanced Raman scattering (SERS) tag microsphere and preparation method thereof

The invention belongs to the technical fields of materials and biology, and in particular relates to a surface-enhanced Raman scattering (SERS) tag microsphere and a preparation method thereof. The preparation method comprises the following steps of: reducing silver nitrate solution by using a reducing agent by taking a polymer microsphere of which the surface is provided with a carboxyl functional group as a template by an in-situ chemical reduction method to prepare a composite microsphere with uniform and compact surface silver nanoparticle coverage degree; and cladding a silicon dioxide shell by using a chemical adsorption Raman probe molecule and a silane coupling agent by a sol-gel method to obtain the SERS tag microsphere with high SERS activity. The SERS tag microsphere has monodispersity, high stability and high biocompatibility, a silicon dioxide surface is easily modified into functional groups such as an amino group or carboxyl and the like, and the SERS tag microsphere is chemically combined with a biomolecule and is applied to the fields of immunoassay, biomedical imaging, disease treatment and the like. The method is easy to operate, and has a controllable process and a good application prospect.
Owner:FUDAN UNIV

Photocatalytic inorganic nanoparticle/polydopamine/polymer self-cleaning composite film and preparation method thereof

The invention belongs to the technical field of films, and in particular relates to a photocatalytic inorganic nanoparticle / polydopamine / polymer self-cleaning composite film and a preparation method thereof. According to the preparation method, photocatalytic inorganic nanoparticles are modified to the surface of the composite film by using a chemical binding method, so that the stability of the inorganic nanoparticles on the surface of the composite film is improved, and the contact of the inorganic nanoparticles with pollutants is prompted so as to improve the photo-degradation efficiency of the inorganic nanoparticles, therefore, the self-cleaning capability of the composite film is improved. In addition, as polydopamine is used as a free group quencher, a polymer matrix is effectively prevented from being degraded when being affected by the photocatalytic inorganic nanoparticles in the UV (Ultraviolet) radiation process, so that the property stability of the composite film is improved, and the service life of the composite film is prolonged. The preparation method is simple in operation process, gentle in preparation condition, low in production cost and easy for in-batch and in-scale production, and has a good industrialization production basis and a wide application prospect.
Owner:FUDAN UNIV

Flue gas conversion apparatus and method

InactiveUS7252806B1Energy penalty of operating the apparatus will be minimizedCombination devicesGas treatmentAtmospheric airEngineering
An apparatus and method of converting flue gases produced by a fossil fuel burning furnace boiler is disclosed. The flue gas is separated into its constituent parts by cooling and filtering. Carbon dioxide, the main constituent, is then converted to carbon monoxide in a laser powered gas converter in which carbon is a catalyst. The laser powered converter also produces hydrogen from steam, and the two newly produced gases are chemically combined to produce a hydrocarbon fuel product which can then be burned in the furnace boiler. In this manner no harmful greenhouse gases are permitted to escape to the atmosphere.
Owner:PET PROJECTS

Breakpoint fusion fragment complementation system

InactiveUS20040038317A1Peptide librariesAntibody mimetics/scaffoldsHeterologousRNA-Protein Interaction
Fragment pairs of a Class A beta-lactamase (TEM-1 of E. coli) are disclosed that depend for their functional reassembly into the parent protein on the interaction of heterologous polypeptides or other molecules which have been genetically or chemically conjugated to the break-point termini of the fragment pairs. In addition, methods are provided for identifying fragment pairs that will optimally reassemble into a functional parent protein. Fragment pairs that comprise molecular interaction-dependent enzymes find use in (1) homogeneous assays and biosensors for any analyte having two or more independent binding sites, (2) tissue-localized activation of therapeutic and imaging reagents in vivo for early detection and treatment of cancer, chronic inflammation, atherosclerosis, amyloidosis, infection, transplant rejection, and other pathologies, (3 cell-based sensors for activation or inhibition of metabolic or signal transduction pathways for high-efficiency, high-throughput screening for agonists / antagonists of the target pathway, (4) high-throughput mapping of pair-wise protein-protein interactions within and between the proteomes of cells, tissues, and pathogenic organisms, (5) rapid selection of antibody fragments or other binding proteins which bind specifically to polypeptides of interest, (6) rapid antigen identification for anti-cell and anti-tissue antibodies, (7) rapid epitope identification for antibodies, (10) cell-based screens for high-throughput selection of inhibitors of any protein-protein interaction.
Owner:KALOBIOS PHARMA

Bonded assemblies and methods for improving bond strength of a joint

Bonded assemblies and methods for improving the bond strength of a joint are provided. The joint may be formed between bonding surfaces of a first and a second component. The first component has a bonding surface adapted to be bonded to a bonding surface of a second component. A plurality of features may be formed in at least one of the bonding surfaces. The bonding surfaces are bonded together to form the joint. A bonding material layer between the bonding surfaces may form the joint or the first and second components may be co-cured to form the joint. A chemical and mechanical bond between the bonding surfaces is formed with the plurality of features forming the mechanical bond and increasing the bond area of the chemical bond. The features may be openings and / or protrusions such as holes, slots, and bosses.
Owner:HONEYWELL INT INC

Neutrophil gelatinase-associated lipocalin (NGAL) protein level ELISA kit

Disclosed is a neutrophil gelatinase-associated lipocalin (NGAL) protein level ELISA kit which is composed of a reagent I and a reagent II. The reagent I comprises a slow-release agent and a denaturant; the reagent II comprises latex particles coated with NGAL antibodies. Aggregated protein is denatured to some extent after being added with the denaturant, physical and (or) chemical binding site is exposed, chemical binding action of the chemical binding site is fractured through sulfydryl dissociation agent , while physical binding action of the physical binding site is dispersed by surface active agent, so that the aggregated protein is disaggregated. Therefore, it is quite important to choose the appropriate types and concentrations of denaturant, sulfydryl dissociation agent, and surface active agent; the aggregate is disaggregated without interference on following immunological detection. According to the method, the the appropriate types and concentrations of denaturant, sulfydryl dissociation agent and surface active agent are determined and chosen specifically, which solves the technical problem above.
Owner:NINGBO MEDICAL SYSTEM BIOTECHNOLOGY CO LTD

Preparation method for molecular sieve coating material on porous silicon carbide ceramic surface

The invention relates to a preparation technique for a molecular sieve coating material, in particular to a preparation method for a molecular sieve coating material on a porous silicon carbide ceramic surface. Porous silicon carbide ceramic is used as a carrier, solid raw materials such as silicon blocks, quartz, silicon-aluminum composite oxide sintered powder with adjustable silicon-aluminum atomic ratio and the like are used as a silicon source or a silicon-aluminum source, and the raw materials are synthesized through in-situ hydrothermal reaction. The porous silicon carbide ceramic surface is provided with microporous structures. The use of the solid silicon source or silicon-aluminum source can enable the release speed of the silicon source or silicon-aluminum source for the growth of crystal nucleus to be controllable. Thereby, the prepared molecular sieve coating is evenly loaded on the surface of the silicon carbide ceramic carrier, the silicon-to-aluminum ratio can be accurately controlled, and the composite material formed by the molecular sieve and the porous silicon carbide ceramic has unique microporous / macroporous structures; and the chemical bonding between the molecular sieve and the porous silicon carbide ceramic is realized and the interfacial bonding strength is high. The invention has the advantages that the technology of the method is simple, the operation is convenient, the complex equipment is not required, the preparation cost is low and the method is more suitable for industrialized mass production.
Owner:INST OF METAL RESEARCH - CHINESE ACAD OF SCI

Lamellar ordered hybrid coating film and preparation method thereof

ActiveCN102051100ARealize layer-by-layer assemblyRealize Orientation AlignmentSynthetic resin layered productsCoatingsSurface-active agentsMechanical property
The invention discloses a lamellar ordered hybrid coating film. The lamellar ordered hybrid coating film with thickness ranging from 500 nm to 40 mum is formed by alternately piling inorganic nano-particle layers with thicknesses ranging from 10 nm to 200 nm and polymer layers with thicknesses ranging from 50 nm to 5 mum; each inorganic nano-particle layer adopts a montmorillonite layer or hydrotalcite layer; the polymer layer is prepared by a polymer emulsion coating film; and the polymer emulsion is prepared by adopting the following method: adding a monomer, surface-active agent and initiating agent into deionized water to carry out polymerization reaction for 5 to 8 hours under the temperature of 50 DEG C to 80 DEG C, then cooling to room temperature after completion of reaction, and then obtaining the polymer emulsion. The lamellar ordered hybrid coating film material is prepared by adopting the alternately spincoating or spraying method, the thicknesses of the polymer layers and the norganic nano-particle layers can be controlled through the process; and in addition, the surface-active agent capable of taking part in polymerization is selected, and the chemical binding between inorganic platy particles and polymer phase can be realized, so that the mechanical property, the heat resistance, the corrosion resistance and other properties of the material are enhanced.
Owner:ZHEJIANG UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products